Rapidly Involuting Congenital Hemangioma (RICH)

Rapidly Involuting Congenital Hemangioma, also known as rich, is related to capillary hemangioma and hemangioma. An important gene associated with Rapidly Involuting Congenital Hemangioma is SLC2A1 (Solute Carrier Family 2 Member 1), and among its related pathways/superpathways are Thromboxane signalling through TP receptor and Chaperonin-mediated protein folding. The drugs Linagliptin and Nitroglycerin have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and bone, and related phenotypes are hemangioma and telangiectasia of the skin